Do you routinely administer desmopressin to patients with intracerebral hemorrhage who are also on anti-platelet therapy?  

At our institution, we always administer desmopressin (0.4 micrograms/kg) for patients on anti-platelet therapy with intracranial hemorrhage, regardless of the etiology. There is no high-level data to guide this practice. We performed a retrospective review of patients admitted to the University of ...